CABERGOLINE Tablets recall: Impurity Out of Spec
CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88
Why was CABERGOLINE Tablets recalled?
Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot number 6A007046V, exp 07/12
- Product
- CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88
- Recalling firm
- Teva Pharmaceuticals USA, Inc.
- Quantity
- 13,232 bottles
- Distribution
- Nationwide
- Recall date
- January 23, 2013
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)